FDA: Only 76,837 adverse events after administration of 75 M COVID-19 vaccine doses



menu

Sections



search


Today’s Paper



insert_drive_file






Close



newsinfo /

Nation


Nation

FDA: Only 76,837 adverse events after administration of 75 M COVID-19 vaccine doses


INQUIRER.net

/ 01:14 PM November 25, 2021



NO FEAR – A teenager from Baguio receives her COVID-19 vaccine during the ceremonial rollout of the city’s adolescent vaccination program on Oct. 29. —EV ESPIRITU

MANILA, Philippines — The Food and Drug Administration (FDA) has recorded only 76,837 adverse events following immunization (AEFI) or 0.1 percent of more than 75 million vaccinations against COVID-19.

“So far, our suspected adverse events are less than 0.1 percent of total doses administered, but we’ve had reports of 76,000, and a majority of them are very mild. Only 0.005 percent (3,874) are serious adverse reactions,” FDA Director General Eric Domingo said in a webinar, citing government data as of November 21.


ADVERTISEMENT

The FDA defines AEFI as “any untoward event that follows immunization and that

does not necessarily have a causal relationship with the usage of the vaccine.”
“The adverse event may be an unfavorable or unintended sign, abnormal laboratory symptom or disease,” Domingo said in his presentation.
The Department of Health earlier said that some serious adverse events experienced by few vaccine recipients are difficulty in breathing and chest pain.

“In our country, the most common things that are reported are an increase in blood pressure, especially before and right after vaccination. Of course, patients tend to be anxious on the day of vaccination. A fever would be the second one, headaches, pain on the area of vaccination, panghihina (fatigue), some get chills, muscle pain, cough, dizziness, and tiredness. These are the most common adverse events that we see,” Domingo said.

Despite these AEFI reports, Domingo stressed that all vaccines in the national immunization program are safe and effective.

FEATURED STORIES
NEWSINFO


DQ petitions vs Bongbong Marcos: Casting cloud of doubt

NEWSINFO


The Chinese dad making medicine to treat his dying son

NEWSINFO


While COVID cases in PH decline, number of patients in critical condition doubles

He added that the majority of events thought to be related to the administration of a vaccine are “actually not due to the vaccine itself” and that many are “simply coincidental events.”

gsg

Subscribe to our daily newsletter


For more news about the novel coronavirus click

here.



What you need to know about Coronavirus.



For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this


link

.


Read Next


Dump truck falls into ravine in Kalinga; 15 rescued


EDITORS’ PICK


MOST READ


Don’t miss out on the latest news and information.







View comments

Subscribe to

INQUIRER PLUS

to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.


TAGS:

adverse events following immunization

,

coronavirus Philippines

,

COVID-19

,

COVID-19 Vaccine

,

Eric Domingo

,

Food and Drug Administration

For feedback, complaints, or inquiries,

contact us.

newsinfo



Ex-Duterte adviser Michael Yang seeks SC help vs Senate arrest orders

November 25, 2021

sports



Casual remark over the phone sparked EJ Obiena controversy

November 25, 2021

newsinfo



Comelec junks motion vs extended deadline for Marcos’ reply on DQ case

November 25, 2021

opinion



‘We’re defeated already’

November 25, 2021

newsinfo



4 parties form ‘UniTeam’ alliance for Bongbong Marcos – Sara Duterte tandem

November 25, 2021

globalnation



China insists on PH commitment to remove Navy outpost at Ayungin Shoal

November 25, 2021

Subscribe to our daily newsletter

providing an email address. I agree to the

Terms of Use

and

acknowledge that I have read the

Privacy Policy

.


Disclaimer:

Comments do not represent the views of INQUIRER.net. We reserve the right to exclude comments which are inconsistent with our editorial standards.

FULL DISCLAIMER

© Copyright 1997-2021 INQUIRER.net All Rights Reserved

We use cookies to ensure you get the best experience on our website. continuing, you are agreeing to our use of cookies. To find out more,

please click this link.